Skip to main content

Kymera Therapeutics, Inc.

KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815442

In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Kymera Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
8 filings
5 insiders, $93.3M in total
Insiders trading
5
Net value
−$93.3M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Kymera Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Kymera Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Adams BrianChief Legal Officer50,254Sep 4, 20262
Rooney TerenceChief Medical Officer38,000Jul 27, 20261
Mainolfi NelloChief Executive Officer666,568Jul 7, 202610
Jacobs Bruce N.Chief Financial Officer244,883Jul 2, 20264
Goodman NoahChief Business Officer47,179Jul 2, 20266
Booth BruceDirector462,856IndirectJul 2, 202612
Biotechnology Value Fund L PDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF Partners L PDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF IncDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Biotechnology Value Fund II LPDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Lampert Mark NDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Biotechnology Value Trading Fund OS LPDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF Partners OS Ltd.Director, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF I GP LLCDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF II GP LLCDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF GP Holdings LLCDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Baker JulianDirector, 10% Owner7,955,916IndirectJun 25, 20262
Baker FelixDirector, 10% Owner7,955,916IndirectJun 25, 20262
Baker Bros. Advisors LPDirector, 10% Owner7,955,916IndirectJun 25, 20262
Baker Brothers Life Sciences LPDirector, 10% Owner7,955,916IndirectJun 25, 20262
667, L.P.Director, 10% Owner7,955,916IndirectJun 25, 20262
Baker Bros. Advisors (GP) LLCDirector, 10% Owner7,955,916IndirectJun 25, 20262
Maraganore JohnDirector–Jun 25, 20261
Sandor VictorDirector–Jun 25, 20261
Albers Jeffrey W.Director0Jun 25, 20263
Esposito PamelaDirector1,000Jun 25, 20266
Ridloff ElenaDirector0Jun 25, 20263
Hrustanovic GorjanDirector–Jun 25, 20261
Chadwick Jeremy GChief Operating Officer44,018May 27, 20267
Gollob JaredChief Medical Officer117,134Mar 4, 20264
Chiniara EllenChief Legal Officer80,085Mar 3, 20250
Morgan LeighDirector–Jun 20, 20240
Horobin JoannaDirector0Jun 7, 20240
Atlas Venture Fund X, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates X, LLC10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates X, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Opportunity Fund I, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates Opportunity I, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates Opportunity I, LLC10% Owner828,830IndirectMar 13, 20240
Caughey ElaineChief Business Officer18,986Mar 3, 20230
Nicholson Donald WilliamDirector–Jun 16, 20220
Chesworth RichardChief Scientific Officer0Aug 27, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 4, 2026 (view filing)6:00 PM ETSep 4Same dayAdams BrianChief Legal OfficerSSale−6.37K$116.83−$744.3K−11.3%50.3K after3 lots
Jul 7, 2026 (view filing)8:00 PM ETJul 7Same dayMainolfi NelloChief Executive OfficerSSale−50.0K$119.00−$5.95M−7.0%666.6K after10b5-1
Jul 2, 2026 (view filing)6:30 PM ETJun 302 daysJacobs Bruce N.Chief Financial OfficerSSale−77.1K$114.96−$8.86M−23.9%244.9K after8 lots10b5-1
Jul 2, 2026 (view filing)6:30 PM ETJul 11 dayGoodman NoahChief Business OfficerSSale−3.39K$114.29−$387.3K−6.7%47.2K after10b5-1
Jul 2, 2026 (view filing)6:30 PM ETJul 11 dayMainolfi NelloChief Executive OfficerSSale−80.0K$115.29−$9.22M−10.7%666.6K after5 lots10b5-1
Jul 2, 2026 (view filing)5:39 PM ETJun 293 daysBooth BruceDirectorSSale−76.7K$108.05−$8.28M−14.2%462.9K afterAmended14 lots10b5-1
Jun 30, 2026 (view filing)Jun 291 dayBooth BruceDirectorSSale−31.3K$109.48−$3.42M−6.3%461.8K after8 lots10b5-1
Jun 30, 2026 (view filing)Jun 26-294 daysBooth BruceDirectorSSale−513.2K$110.01−$56.5M−52.4%466.1K after30 lots10b5-1
Jun 26, 2026 (view filing)6:48 PM ETJun 26Same dayBiotechnology Value Fund L P and 9 othersDirector, Other: See Remarks and FootnotesSSaleCommon Stock, $0.0001 par value−1.58M$106.50−$168.1M−86.8%240.1K after3 lots
Jun 26, 2026 (view filing)6:48 PM ETJun 26Same dayBiotechnology Value Fund L P and 9 othersDirector, Other: See Remarks and FootnotesSSaleCommon Stock, $0.0001 par value−51.9K$106.50−$5.52M−39.7%78.8K after
Jun 25, 2026 (view filing)Jun 25Same dayBooth BruceDirectorSSale−285.7K$121.86−$34.8M−35.0%529.7K after22 lots10b5-1
Jun 25, 2026 (view filing)Jun 23-252 daysBooth BruceDirectorSSale−398.8K$110.31−$44.0M−41.4%564.7K after30 lots10b5-1
Jun 25, 2026 (view filing)Jun 25Same dayGoodman NoahChief Business OfficerSSale−5.00K$114.00−$570.0K−9.1%50.2K after2 lots10b5-1
Jun 22, 2026 (view filing)Jun 22Same dayBooth BruceDirectorSSale−31.8K$103.75−$3.30M−4.9%613.8K after4 lots10b5-1
Jun 22, 2026 (view filing)Jun 175 daysBooth BruceDirectorSSale−11.7K$89.98−$1.06M−100.0%0 after10b5-1
Jun 22, 2026 (view filing)Jun 17-225 daysBooth BruceDirectorSSale−466.5K$94.84−$44.2M−43.0%617.7K after28 lots10b5-1
Jun 22, 2026 (view filing)Jun 22Same dayGoodman NoahChief Business OfficerSSale−2.50K$99.00−$247.5K−4.7%50.2K after10b5-1
May 27, 2026 (view filing)May 26-271 dayChadwick Jeremy GChief Operating OfficerSSale−17.2K$79.92−$1.37M−28.1%44.0K after7 lots10b5-1
May 11, 2026 (view filing)May 11Same dayRidloff ElenaDirectorSSale−3.00K$87.00−$261.0K−100.0%0 after10b5-1
Apr 29, 2026 (view filing)Apr 29Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$81.18−$2.44M−4.3%666.2K after3 lots10b5-1
Apr 24, 2026 (view filing)Apr 222 daysBooth BruceDirectorSSale−5.90K$89.96−$530.8K−100.0%0 after10b5-1
Apr 24, 2026 (view filing)Apr 222 daysBooth BruceDirectorSSale−100$90.08−$9.01K0.0%674.9K after2 lots10b5-1
Apr 24, 2026 (view filing)Apr 222 daysChadwick Jeremy GChief Operating OfficerSSale−300$90.00−$27.0K−0.5%61.2K after10b5-1
Apr 16, 2026 (view filing)Apr 14-152 daysBooth BruceDirectorSSale−6.36K$89.96−$572.1K−100.0%0 after2 lots10b5-1
Apr 16, 2026 (view filing)Apr 151 dayBooth BruceDirectorSSale−3.13K$90.10−$282.5K−0.5%675.0K after2 lots10b5-1
Apr 16, 2026 (view filing)Apr 142 daysGoodman NoahChief Business OfficerSSale−1.35K$90.00−$121.2K−2.6%50.2K after10b5-1
Apr 16, 2026 (view filing)Apr 14-152 daysChadwick Jeremy GChief Operating OfficerSSale−6.55K$90.00−$589.6K−9.7%61.2K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 9-101 dayGoodman NoahChief Business OfficerSSale−10.3K$87.47−$897.8K−16.6%51.5K after4 lots10b5-1
Apr 1, 2026 (view filing)Mar 31-Apr 11 dayRidloff ElenaDirectorSSale−12.0K$85.39−$1.02M−100.0%0 after3 lots10b5-1
Apr 1, 2026 (view filing)Mar 31-Apr 11 dayChadwick Jeremy GChief Operating OfficerSSale−22.2K$85.43−$1.90M−26.7%61.2K after3 lots10b5-1
Mar 25, 2026 (view filing)Mar 23-252 daysChadwick Jeremy GChief Operating OfficerSSale−116.0K$78.02−$9.05M−65.5%61.2K after6 lots10b5-1
Mar 20, 2026 (view filing)Mar 20Same dayEsposito PamelaDirectorSSale−2.50K$79.15−$197.9K−100.0%0 after3 lots10b5-1
Mar 11, 2026 (view filing)Mar 11Same dayChadwick Jeremy GChief Operating OfficerSSale−25.8K$83.30−$2.15M−27.5%68.1K after3 lots10b5-1
Mar 4, 2026 (view filing)Mar 22 daysBooth BruceDirectorSSale−81.9K$90.13−$7.38M−10.8%675.3K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 2-42 daysChadwick Jeremy GChief Operating OfficerSSale−5.96K$86.54−$515.6K−7.5%73.8K after7 lots
Mar 4, 2026 (view filing)Mar 2-42 daysGollob JaredChief Medical OfficerSSale−10.5K$87.24−$916.7K−8.2%117.1K after7 lots
Mar 4, 2026 (view filing)Mar 2-42 daysJacobs Bruce N.Chief Financial OfficerSSale−12.5K$87.50−$1.09M−5.1%232.6K after7 lots
Feb 25, 2026 (view filing)Feb 25Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$90.26−$2.71M−4.3%666.2K after5 lots10b5-1
Feb 20, 2026 (view filing)Feb 20Same dayEsposito PamelaDirectorSSale−2.50K$87.31−$218.3K−100.0%0 after2 lots10b5-1
Jan 20, 2026 (view filing)Jan 20Same dayEsposito PamelaDirectorSSale−5.50K$67.91−$373.5K−100.0%0 after3 lots10b5-1
Dec 31, 2025 (view filing)Dec 31Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$78.06−$2.34M−4.3%663.1K after2 lots10b5-1
Dec 17, 2025 (view filing)Dec 17Same dayEsposito PamelaDirectorSSale−27.6K$82.16−$2.26M−100.0%0 after4 lots10b5-1
Dec 12, 2025 (view filing)Dec 10-122 daysBooth BruceDirectorSSale−236.6K$91.72−$21.7M−25.7%685.4K after14 lots
Dec 11, 2025 (view filing)4:19 PM ETDec 11Same dayBaker Julian and 5 othersDirector, 10% OwnerPPurchase+2.01M$86.00+$172.5M+33.7%7.96M after2 lots
Dec 8, 2025 (view filing)Dec 8Same dayAlbers Jeffrey W.DirectorSSale−5.00K$89.76−$448.8K−100.0%0 after2 lots10b5-1
Dec 8, 2025 (view filing)Dec 8Same dayMainolfi NelloChief Executive OfficerSSale−100.0K$89.17−$8.92M−13.1%660.5K after10b5-1
Dec 8, 2025 (view filing)Dec 8Same dayGollob JaredChief Medical OfficerSSale−49.3K$88.66−$4.37M−31.0%110.0K after6 lots10b5-1
Oct 29, 2025 (view filing)Oct 29Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$60.99−$1.83M−4.3%660.5K after3 lots10b5-1
Oct 15, 2025 (view filing)Oct 15Same dayGollob JaredChief Medical OfficerSSale−59.6K$61.42−$3.66M−35.1%110.0K after4 lots10b5-1
Oct 14, 2025 (view filing)Oct 131 dayGollob JaredChief Medical OfficerSSale−3.11K$60.00−$186.8K−2.6%118.4K after10b5-1